SARS-CoV-2 infections have led to a surge in long COVID, a post-infectious syndrome in which autoantibodies are proposed to play a pathogenic role, analogous to fibromyalgia. Here, we test this hypothesis by transferring total IgG from long COVID patients into mice. We stratified patients into three subgroups using plasma levels of glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL), and interferon-β, with subgroup-specific pathways supported by plasma proteomics. Transfer of pooled total IgG induces pronounced and persistent mechanical hypersensitivity. Notably, IgG collected 2 years later from the same long COVID patients who remained symptomatic reproduced mechanical allodynia in mice, demonstrating longitudinal stability of pathogenic activity. Proteome-wide autoantibody profiling identifies elevated, subgroup-linked autoreactivities that persist over time and are validated by independent assays. Together, these findings demonstrate that long COVID IgG can induce mechanical hypersensitivity in mice, support a causal role for autoantibodies in long COVID pathogenesis, and may establish a murine model for therapeutic development.
Transfer of IgG from long COVID patients induces symptomology in mice
24 mars 2026|Cell Reports Medicine

Vous avez des difficultés à accéder au matériel ? Essayez ici.
Contenu Associé

APCOVID-19 : étude nationale sur la prévalence et l’impact de l’affection post-COVID-19
A partir du 1er septembre 2022, Santé publique France lance une étude afin d’estimer la prévalenc...

COVID-19 sévère et maladies auto-immunes ou inflammatoires incidentes : une étude épidémiologique nationale à partir des données du PMSI en 2020
Début août 2022, l’Organisation mondiale de la santé (OMS) recense plus de 580 millions de cas mo...